KRAS Subtype Modifies Outcomes with Immunomodulatory Therapy in Advanced Pancreatic Ductal Adenocarcinoma: Evidence from Early-Phase Trials.
Saved in:
| Title: | KRAS Subtype Modifies Outcomes with Immunomodulatory Therapy in Advanced Pancreatic Ductal Adenocarcinoma: Evidence from Early-Phase Trials. |
|---|---|
| Authors: | Mizrak Kaya, Dilsa1,2 (AUTHOR), Ma, Yangruijue2,3 (AUTHOR), Demir, Tarik1,3,4 (AUTHOR), Altomare, Nicole J.4,5 (AUTHOR), Kalyan, Aparna1,5 (AUTHOR), Kircher, Sheetal1,5 (AUTHOR), Mulcahy, Mary2,5 (AUTHOR), Benson III, Al B.3,5 (AUTHOR), Chen, Ruohui3,4 (AUTHOR), Mahalingam, Devalingam1,5 (AUTHOR) mahalingam@nm.org |
| Source: | Cancers. Jul2026, Vol. 18 Issue 13, p2037. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 195444729 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: KRAS Subtype Modifies Outcomes with Immunomodulatory Therapy in Advanced Pancreatic Ductal Adenocarcinoma: Evidence from Early-Phase Trials. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Mizrak+Kaya%2C+Dilsa%22">Mizrak Kaya, Dilsa</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ma%2C+Yangruijue%22">Ma, Yangruijue</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Demir%2C+Tarik%22">Demir, Tarik</searchLink><relatesTo>1,3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Altomare%2C+Nicole+J%2E%22">Altomare, Nicole J.</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kalyan%2C+Aparna%22">Kalyan, Aparna</searchLink><relatesTo>1,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kircher%2C+Sheetal%22">Kircher, Sheetal</searchLink><relatesTo>1,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mulcahy%2C+Mary%22">Mulcahy, Mary</searchLink><relatesTo>2,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Benson+III%2C+Al+B%2E%22">Benson III, Al B.</searchLink><relatesTo>3,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Ruohui%22">Chen, Ruohui</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mahalingam%2C+Devalingam%22">Mahalingam, Devalingam</searchLink><relatesTo>1,5</relatesTo> (AUTHOR)<i> mahalingam@nm.org</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancers%22">Cancers</searchLink>. Jul2026, Vol. 18 Issue 13, p2037. 16p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=195444729 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/cancers18132037 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 16 StartPage: 2037 Titles: – TitleFull: KRAS Subtype Modifies Outcomes with Immunomodulatory Therapy in Advanced Pancreatic Ductal Adenocarcinoma: Evidence from Early-Phase Trials. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mizrak Kaya, Dilsa – PersonEntity: Name: NameFull: Ma, Yangruijue – PersonEntity: Name: NameFull: Demir, Tarik – PersonEntity: Name: NameFull: Altomare, Nicole J. – PersonEntity: Name: NameFull: Kalyan, Aparna – PersonEntity: Name: NameFull: Kircher, Sheetal – PersonEntity: Name: NameFull: Mulcahy, Mary – PersonEntity: Name: NameFull: Benson III, Al B. – PersonEntity: Name: NameFull: Chen, Ruohui – PersonEntity: Name: NameFull: Mahalingam, Devalingam IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: Jul2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 20726694 Numbering: – Type: volume Value: 18 – Type: issue Value: 13 Titles: – TitleFull: Cancers Type: main |
| ResultId | 1 |